Gas Chromatography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
The Gas Chromatography market was expected to witness a CAGR of 5.6% during the forecast period.
The COVID-19 pandemic is likely to have a slightly positive effect on the market. A study conducted in December 2020 and was published in 'The Lancet'. The study looked into gas chromatography techniques that can rapidly distinguish COVID-19 from other respiratory conditions, which can include influenza during the first diagnosis. The study was conducted at two sites in Edinburgh and Dortmund. Results from both sites indicated that patients who had contracted COVID-19 can be rapidly distinguished from patients with other conditions by gas chromatography methods at first healthcare contact. Novel uses of Gas Chromatography in the fight against COVID-19 are expected to boost the market growth.
The factors that are driving the market growth include increasing food safety concerns, the growing importance of chromatography tests in the drug approval process, and rising adoption of GC-MS.
Gas chromatography (GC) is widely accepted in both scientific and legal arenas, as one of the most powerful analytical techniques for separation, quantification, and identification of drug analytes, especially at low levels of concentration. GC is mostly done to analyze compounds that can be vaporized without decomposition. Gas chromatography is used extensively to test the purity of substances and to separate a mixture into its basic components. It has a profound use in analytical chemistry, owing to its ability to offer excellent features, like accurate separation capabilities, reproducibility, and quicker separation.
It is used in different fields, such as pharmaceuticals, cosmetics, and environmental toxins. Moreover, it can be used to analyze samples, which are volatile like exhaled human breath, blood, saliva, and other secretions. Air samples can be analyzed by using GC. Most of the air quality control units use GC coupled flame ionization detector (FID) to determine the components of a given sample.
Gas chromatography/ mass spectroscopy (GC/MS) is another useful method for determining the components of a given mixture, using the retention times and the abundance of the samples. GC method is used in many pharmaceutical applications, such as identifying the amount of chemical in drugs. Moreover, cosmetic manufacturers prefer GC technique to effectively measure the chemicals used in their products. Moreover, the European Medical Agency (EMA) has similar guidelines for drug analytics. Identification to discriminate between compounds of closely related structures are mostly done through GC/MS or HPLC/MS systems. However, the European Medical Agency does not consider the interpretation by chromatography techniques as specific.
Additionally, the use of GC and liquid chromatography for drug testing, especially to determine the purity and efficacy of new drug analytes has been approved by the National Institute of Health Sciences (NIHS), Japan. Thus, increased use of gas chromatography in drug approvals and growing support from the government, in the form of funds, are boosting the market growth
Gas chromatography (GC) was introduced over 60 years ago, and has since become a cornerstone technique for analytical chemistry. Advances in the area of column technology, such as the commercialization of high temperature stationary phases and silica capillaries stable to 480°C, has recently been put in the place. New materials such as sol-gel poly(ethylene glycol), nanoparticles, ionic liquids, and co-polymers have been incorporated in several novel Gas Chromatography stationary phases. Stationary phases have also been discussed for a long time in relation to microfabricated GC, i.e. chip-based GC. Such advancements are expected to propel the market growth over the forecast period all across the globe.
Pharmaceutical & BioIndustries are Expected to Hold Significant Market Share in the Application Segment
The COVID-19 pandemic is expected to have a positive effect on this segment. Since the pharmaceutical and bioindustry sectors have received huge amount of attention recently, this is expected to positively aid in the development of the gas chromatography market. In July 2020, an article was released in the 'Chromatography Today' magazine which stated that the US Air Force and researchers from the University of Michigan had collaborated to make modifications to an existing gas analysis system so that it can work like a breathalyser that can analyze the breath and detect the chemical signature of Acute Respiratory Distress Syndrome (ARDS) in its very early stages, which is a precursor to most COVID-19 infections. Developments such as these are expected to positively aid market growth.
The high efficiencies of separation power, the extreme detection sensitivity while detecting small amounts of separated species, and the accuracy and precision of the data from quantitative analyses of extremely complex mixtures are the major reasons why GC is used in the pharmaceutical industry. GC analyses are also less hassle-free while automating from sample introduction to separation. GC-MS is exclusively used in bio-analysis of blood, urine for the presence of barbiturates, alcohols, narcotics, residual solvents, drugs, like anesthetics, antihistamine, anticonvulsant, anti-epileptic drug, sedative hypnotics, and food items. Toxins and venoms can also be identified by GC-MS. It is extensively used in clinical toxicology too.
Rise in government funding in pharmaceutical R&D, technological advancements in the area of analytical instruments, increasing life science R&D expenditure, progressing drug discovery, and an increase in the adoption of GC are the key factors driving the growth of gas chromatography market, in the pharmaceutical and biotechnology industry. As a result of the aforementioned main advantages, short analysis time needed and reliable results, GC is extensively used as quality control purposes in the pharmaceutical and biotechnology industry.
North America Dominates the Market and Expected to do Same in the Forecast Period
In the North American region, gas chromatography technology is used in many applications. Chromatography instrumentation has proven to be an effective technology for final production testing, pharmaceutical applications, environmental monitoring, and food testing, among others. Pharmaceutical organizations utilize gas chromatography, in order to get large amounts of greatly immaculate materials, and to examine the cleansed mixes. Other factors propelling the growth of the North American gas chromatography market, include the increasing need for drug discovery, rising prevalence of chronic diseases, and augmented demand for personalized medicines. The increasing focus on the development of improved and novel drug assessment techniques which has been used to discover highly complex drugs is playing a vital role in the evolution of new chromatographic methods in the region. In May 2017, Shimadzu Scientific Instruments (SSI) released its new Nexis GC-2030 gas chromatograph, offering a modern approach to a classic chromatographic technique.
The increased adoption of chromatography technique, majorly in food and beverage and pharmaceutical industries, drives the demand for gas chromatography in the region. With the rising number of critical diseases and the increase in the geriatric population in the region, healthcare expenditure has increased significantly in the region. This has increased R&D investments into the pharmaceutical industry for drug discovery and production, which has further increased the demand for chromatography technique in the North American region.
The Gas Chromatography market is highly competitive and consists of a number of players. Companies like Agilent Technologies, Inc., Chromatotec, Restek Corporation, Danaher Corporation, Merck KgaA, Falcon Analytical Systems &Technology, LLC, PerkinElmer, Inc., Scion instruments, Shimadzu Corporation, Thermo Fisher Scientific, Inc., among others, hold the substantial market share in the Gas Chromatography market.
Many strategic initiatives have taken recently in the market by the major players. For example, in January 2021, Sartorius announced it had entered into an agreement to acquire the chromatography process equipment division of Novasep.